Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-27 @ 11:09 PM
Study NCT ID:
NCT04657094
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-27
First Post:
2020-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-16
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-02-27
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-01
First Submit QC Date:
None
Study First Post Date:
2020-12-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-03-25
Results First Submit QC Date:
None
Results First Post Date:
2024-05-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-21
Last Update Post Date:
2025-04-27
Last Update Post Date Type:
ACTUAL